3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
38
OTHER_GOV
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Sleep Wake Disorders
1
Fatigue
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Anxiety Disorders
1
Interventions
Specimen Handling
68
Magnetic Resonance Spectroscopy
53
Cyclophosphamide
45
Vincristine
38
Radiotherapy
31
Radiation
31
Cisplatin
31
Carboplatin
30
Dexamethasone
27
Etoposide
26
Doxorubicin
25
Biopsy
25
daratumumab
17
Radiotherapy, Intensity-Modulated
17
Prednisone
17
Platinum
16
Paclitaxel
16
Irinotecan
16
Cytarabine
16
durvalumab
15
Gemcitabine
15
1,2-diaminocyclohexaneplatinum II citrate
15
Observation
14
Methotrexate
14
Leucovorin
14
Docetaxel
14
Lenalidomide
13
X-Rays
12
Watchful Waiting
12
Rituximab
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Counseling
×
1 year
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts